Measuring ACPA in the general population or primary care: is it useful?
Rheumatoid arthritis (RA) is associated with a significant disease burden and high costs for society. Because the disease has identifiable preclinical stages, screening and prevention have become a possibility in RA. Anticitrullinated peptide antibodies (ACPAs) are arguably the most likely candidate...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/6/1/e001085.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|